Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Combination of three approved beta-lactams kills MRSA

Dec. 17, 2015

Foundation for Neglected Disease Research announces InhA inhibitors

Dec. 16, 2015

MAT-2501 granted QIDP designation by the FDA

Dec. 15, 2015

ImmBio begins first-in-human studies of PnuBioVax

Dec. 15, 2015

Medshine Discovery introduces anti-HBV compounds

Dec. 14, 2015

FDA grants QIDP status to WCK-5222

Dec. 14, 2015

Gates Foundation funds research for a tapeworm vaccine

Dec. 11, 2015

Vaxart tests influenza vaccine VXA-BYW.10 in healthy adults

Dec. 11, 2015

Tangrun Pharmaceuticals develops HCV NS5A inhibitors

Dec. 10, 2015

Mexico approves Dengvaxia, world's first dengue vaccine

Dec. 10, 2015

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...